Status:
COMPLETED
35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer
Lead Sponsor:
Nakhia Impex LLC
Conditions:
Cancer Pain
Eligibility:
All Genders
48-60 years
Phase:
NA
Brief Summary
HA35 (Bioactive HA or B-HA or HA35) have good tissue permeability (B-HA injection, Ministry of Health, Registration number L20200708MP07707). HA35 might not lose HA's bioactivities of binding to a var...
Detailed Description
The previous study has shown that naked mole rat who has high tissue content of hyaluronan and its fragments is insensitive to pain. The previous study has also shown that hyaluronan modulates pain-re...
Eligibility Criteria
Inclusion
- All patients had different degrees of metastasis of the cancers, including bone metastasis.
- All patients undergo targeted radiotherapy shortly before this study.
- All the patient volunteers included in this study were allowed to use antibiotic compounds on and off during the treatment in order to prevent possible infection associated with the cancers for ethnic consideration.
- The included patients were aged 48 to 60 years.
Exclusion
- Can not independently determine the level of pain.
- Severe bleeding and severe inflammation
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06209970
Start Date
December 20 2023
End Date
March 5 2024
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qingdao Huinorde Science and Technology Co.,Ltd
Qingdao, Shandong, China